Electrolyte and acid-base imbalance in severe COVID-19.

COVID-19 RAAS electrolytes hyperaldosteronism hypernatremia

Journal

Endocrine connections
ISSN: 2049-3614
Titre abrégé: Endocr Connect
Pays: England
ID NLM: 101598413

Informations de publication

Date de publication:
21 Jul 2021
Historique:
received: 27 05 2021
accepted: 22 06 2021
pubmed: 23 6 2021
medline: 23 6 2021
entrez: 22 6 2021
Statut: epublish

Résumé

Acute systemic diseases, such as severe infections, can lead to electrolyte and acid-base alterations. To study the presence of electrolyte imbalance in severe COVID-19, we investigated the frequency and consequences of changes in electrolyte and acid-base patterns over time. We performed a retrospective cohort study including 406 patients with severe COVID-19. Levels of electrolytes, base excess, pH, serum osmolality, and hematocrit, the first 2 weeks of hospitalization, were collected daily from the laboratory database and clinical data from patients' medical records. We found that hyponatremia was present in 57% of the patients at admission and 2% in hypernatremia. However, within 2 weeks of hospitalization 42% of the patients developed hypernatremia, more frequently in critically ill patients. Lower levels of sodium and potassium during admission were associated with the need for mechanical ventilation. Decreased pH at admission was associated with both death and the need for mechanical ventilation. Hypernatremia in the ICU was combined with rising base excess and a higher pH. In the group without intensive care, potassium levels were significantly lower in the patients with severe hypernatremia. Presence of hypernatremia during the first 2 weeks of hospitalization was associated with 3.942 (95% CI 2.269-6.851) times higher odds of death. In summary, hypernatremia was common and associated with longer hospital stay and a higher risk of death, suggesting that the dynamics of sodium are an important indicator of severity in COVID-19.

Identifiants

pubmed: 34156969
doi: 10.1530/EC-21-0265
pii: EC-21-0265
pmc: PMC8346182
doi:
pii:

Types de publication

Journal Article

Langues

eng

Pagination

805-814

Références

Curr Med Res Opin. 2008 Jun;24(6):1601-8
pubmed: 18426691
Crit Care Med. 1999 Jun;27(6):1105-8
pubmed: 10397213
J Clin Endocrinol Metab. 2021 May 13;106(6):1637-1648
pubmed: 33624101
Eur J Endocrinol. 2021 Mar;184(3):409-418
pubmed: 33449918
J Crit Care. 2013 Apr;28(2):214-5
pubmed: 23337488
JAMA Netw Open. 2020 Jun 1;3(6):e2011122
pubmed: 32525548
N Engl J Med. 2007 May 17;356(20):2064-72
pubmed: 17507705
Nefrologia (Engl Ed). 2020 May - Jun;40(3):356-358
pubmed: 32439187
Transpl Infect Dis. 2020 Dec;22(6):e13355
pubmed: 32510756
Anaesthesia. 2009 May;64(5):514-20
pubmed: 19413821
Diagnosis (Berl). 2020 May 26;7(2):91-96
pubmed: 32352401
J Crit Care. 2013 Aug;28(4):405-12
pubmed: 23369520
A A Pract. 2020 Jul;14(9):e01295
pubmed: 32909725
Am J Gastroenterol. 2020 Oct;115(10):1730-1731
pubmed: 32826570
Acta Endocrinol (Buchar). 2020 Jan-Mar;16(1):110-111
pubmed: 32685049
Clin Endocrinol (Oxf). 2019 May;90(5):744-752
pubmed: 30657193
Intensive Care Med. 2010 Oct;36(10):1718-23
pubmed: 20658124
Eur J Clin Invest. 2013 Sep;43(9):933-48
pubmed: 23869476
Am J Kidney Dis. 2007 Dec;50(6):952-7
pubmed: 18037096
Nefrologia (Engl Ed). 2021 Mar-Apr;41(2):219-220
pubmed: 32653253
Front Med (Lausanne). 2020 Jun 09;7:315
pubmed: 32582749
J Crit Care. 2013 Apr;28(2):216.e11-20
pubmed: 22762930
Nephrol Dial Transplant. 2010 Aug;25(8):2510-5
pubmed: 20167570
J Clin Med. 2020 Sep 18;9(9):
pubmed: 32962124
J Endocrinol Invest. 2020 Aug;43(8):1137-1139
pubmed: 32451971
J Thromb Haemost. 2007 Jun;5(6):1185-90
pubmed: 17403099
Clin Exp Nephrol. 2021 Apr;25(4):401-409
pubmed: 33398605
IDCases. 2020 Jun 01;21:e00859
pubmed: 32523871
Ann Clin Biochem. 2021 Mar;58(2):95-101
pubmed: 33103442
EClinicalMedicine. 2020 Aug;25:100449
pubmed: 32838231
Ann Clin Biochem. 2020 May;57(3):262-265
pubmed: 32266828

Auteurs

Anna Sjöström (A)

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden.

Susanne Rysz (S)

Function Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.
Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Henrik Sjöström (H)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Center for Neurology, Academic Specialist Center, Stockholm, Sweden.

Charlotte Höybye (C)

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Department of Endocrinology, Karolinska University Hospital, Stockholm, Sweden.

Classifications MeSH